Biogen Idec Announces Webcast of 2012 Analyst Day
WESTON, Mass.--(BUSINESS WIRE)--Jun. 5, 2012--
Biogen Idec Inc. (NASDAQ: BIIB) announced today that its 2012 Analyst
Day will be webcast live on Tuesday, June 12, 2012 at 10:00 a.m. ET. To
access the live webcast, please visit Biogen Idec’s Investor Relations
section (investor.biogenidec.com). An archived version of the webcast
will be available for 14 days following the presentation.
About Biogen Idec
Through cutting-edge science and medicine, Biogen Idec discovers,
develops and delivers to patients worldwide innovative therapies for the
treatment of neurodegenerative diseases, hemophilia and autoimmune
disorders. Founded in 1978, Biogen Idec is the world’s oldest
independent biotechnology company. Patients worldwide benefit from its
leading multiple sclerosis therapies, and the company generates more
than $5 billion in annual revenues. For product labeling, press releases
and additional information about the company, please visit www.biogenidec.com.
Source: Biogen Idec Inc.
Karen Jewell, 781-464-2442